ABT
Abbott Laboratories
$84.32
-3.09%
2026-05-08
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Key Fundamentals
P/E Ratio
24.34
Forward P/E
14.33
EPS (TTM)
$3.57
ROE
12.3%
Revenue Growth (YoY)
7.8%
Profit Margin
13.9%
Debt/Equity
64.77
Dividend Yield
2.9%
Price/Book
2.91
Beta
0.65
Market Cap
$151.35B
Avg Volume (10D)
13.9M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$116.82
60D Low
$84.08
Avg Volume
10.7M
Latest Close
$84.32
Get breakout alerts for ABT
Sign up for Breakout Scanner to receive daily notifications when ABT triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Abbott Laboratories (ABT) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors ABT daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ABT operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.